{"Symbol": "ABBV", "AssetType": "Common Stock", "Name": "AbbVie Inc", "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.", "CIK": "1551152", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US", "OfficialSite": "https://www.abbvie.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "307413352000", "EBITDA": "26717999000", "PERatio": "72.41", "PEGRatio": "0.381", "BookValue": "1.884", "DividendPerShare": "6.29", "DividendYield": "0.0377", "EPS": "2.4", "RevenuePerShareTTM": "31.84", "ProfitMargin": "0.0759", "OperatingMarginTTM": "0.367", "ReturnOnAssetsTTM": "0.0849", "ReturnOnEquityTTM": "0.623", "RevenueTTM": "56334000000", "GrossProfitTTM": "39645000000", "DilutedEPSTTM": "2.4", "QuarterlyEarningsGrowthYOY": "-0.123", "QuarterlyRevenueGrowthYOY": "0.056", "AnalystTargetPrice": "210.01", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "11", "AnalystRatingHold": "10", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "72.41", "ForwardPE": "14.29", "PriceToSalesRatioTTM": "5.46", "PriceToBookRatio": "92.46", "EVToRevenue": "6.55", "EVToEBITDA": "24.75", "Beta": "0.538", "52WeekHigh": "216.66", "52WeekLow": "148.19", "50DayMovingAverage": "198.65", "200DayMovingAverage": "188.06", "SharesOutstanding": "1768980000", "DividendDate": "2025-05-15", "ExDividendDate": "2025-04-15"}